AQUINOX PHARMACEUTICALS INC - COM (AQXP)

CUSIP: 03842B101

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
22,886,897
Share change
+7,495,265
Total reported value
$305,770,000
Put/Call ratio
30%
Price per share
$13.36
Number of holders
46
Value change
+$100,669,785
Number of buys
32
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 03842B101?
CUSIP 03842B101 identifies AQXP - AQUINOX PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AQUINOX PHARMACEUTICALS INC - COM (AQXP) as of Q3 2016

As of 30 Sep 2016, AQUINOX PHARMACEUTICALS INC - COM (AQXP) was held by 46 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,886,897 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, GOLDMAN SACHS GROUP INC, Boxer Capital, LLC, BlackRock Advisors LLC, NEXTHERA CAPITAL LP, Opaleye Management Inc., and Alyeska Investment Group, L.P.. This page lists 46 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.